BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 955328)

  • 1. The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid.
    Barbara L; Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R
    Digestion; 1976; 14(3):209-19. PubMed ID: 955328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.
    Iser JH; Dowling H; Mok HY; Bell GD
    N Engl J Med; 1975 Aug; 293(8):378-83. PubMed ID: 1152936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of gallstones with chenodeoxycholic acid and phenobarbital.
    Coyne MJ; Bonorris GG; Chung A; Goldstein LI; Lahana D; Schoenfield LJ
    N Engl J Med; 1975 Mar; 292(12):604-7. PubMed ID: 1089875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of chenic acid therapy in patients with cholesterol calculi].
    Roda E; Festi D; Roda A; Sama C; Aldini R; Mazzella G
    Minerva Med; 1977 Sep; 68(43):3027-9. PubMed ID: 909651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fixed doses of chenodeoxycholic acid for gallstone dissolution.
    Bateson MC; Ross PE; Murison J; Bouchier IA
    Lancet; 1978 May; 1(8074):1111-4. PubMed ID: 77412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dissolution of chloresterol biliary calculi with chenodeoxycholic acid].
    Celle G; Ciravegna G; Deconca V; Mansi C; Picciotto A; Savarino V; Dodero M
    Med Chir Dig; 1978; 7(4):321-4. PubMed ID: 672279
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).
    Grundy SM; Lan SP; Lachin J
    J Clin Invest; 1984 Apr; 73(4):1156-66. PubMed ID: 6368591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical management of cholesterol gallstones.
    Abate MA
    Drug Intell Clin Pharm; 1986 Feb; 20(2):106-15. PubMed ID: 3512222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cholesterol saturation of bile and its reduction by chenodeoxycholic acid in massively obese patients.
    Whiting MJ; Hall JC; Iannos J; Roberts HG; Watts JM
    Int J Obes; 1984; 8(6):681-8. PubMed ID: 6533091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prolonged feeding with chenodeoxycholic acid on bile in patients with and without gallstones.
    Bateson MC; Ross PE; Murison J; Bouchier IA
    Gut; 1977 Aug; 18(8):599-605. PubMed ID: 330352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of cholesterol lithiasis with chenodeoxycholic acid (Chenoxyl)].
    Barbara L; Roda E; Roda A; Festi D; Sama C; Mazzella G; Aldini R; Labò G
    Minerva Med; 1975 Feb; 66(12):562-9. PubMed ID: 1113906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in serum total cholesterol and low-density lipoprotein cholesterol by high-dose chenodeoxycholic acid in patients with radiolucent gallstones significantly reversed during preventive low dose after gallstone dissolution.
    Pérez-Aguilar F; Bretó M; Alegre B; Berenguer J
    Digestion; 1985; 31(4):225-33. PubMed ID: 4007294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of chenodeoxycholic acid and dietary cholesterol in the treatment of cholesterol gallstones.
    Doty JE; DenBesten L; Roslyn JJ; Pitt HA; Kuchenbecker SL; Porter-Fink V
    Am J Surg; 1982 Jan; 143(1):48-54. PubMed ID: 7053655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic morphology and bile acid composition of bile and urine during chenodeoxycholic acid therapy for radiolucent gallstones.
    Pedersen L; Bremmelgaard A
    Scand J Gastroenterol; 1976; 11(4):385-9. PubMed ID: 935799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of low-dose and intermittent chenodeoxycholic acid therapy of gallstones.
    Marks JW; Bonorris GG; Chung A; Coyne MJ; Okun R; Lachin JM; Schoenfield LJ
    Am J Dig Dis; 1977 Oct; 22(10):856-60. PubMed ID: 920688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallstone dissolution by chenodeoxycholic acid and phenobarbital.
    Marks JW; Sherman JH; Bonorris GG; Chung A; Coyne MJ; Schoenfield LJ
    Am J Gastroenterol; 1978 Feb; 69(2):160-5. PubMed ID: 352139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criteria for selection of patients for medical treatment (chenodeoxycholic acid therapy) of gallstones.
    Bruusgaard A; Malver E; Pedersen LR; Schlichting P; Sylvest J
    Scand J Gastroenterol; 1977; 12(1):97-102. PubMed ID: 834976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.